NL6716737A - - Google Patents
Info
- Publication number
- NL6716737A NL6716737A NL6716737A NL6716737A NL6716737A NL 6716737 A NL6716737 A NL 6716737A NL 6716737 A NL6716737 A NL 6716737A NL 6716737 A NL6716737 A NL 6716737A NL 6716737 A NL6716737 A NL 6716737A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEB0090219 | 1966-12-09 | ||
| DEB0093416 | 1967-07-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL6716737A true NL6716737A (fr) | 1968-06-10 |
| NL130339C NL130339C (fr) | 1970-12-15 |
Family
ID=25968244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL6716737A NL130339C (fr) | 1966-12-09 | 1967-12-08 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3506643A (fr) |
| AT (2) | AT276640B (fr) |
| CH (2) | CH491119A (fr) |
| FI (1) | FI49302C (fr) |
| FR (2) | FR1550512A (fr) |
| GB (1) | GB1145789A (fr) |
| NL (1) | NL130339C (fr) |
| SE (1) | SE323383B (fr) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2007273A1 (de) * | 1970-02-18 | 1971-08-26 | Boehnnger Mannheim GmbH, 6800 Mann heim Waldhof | N(6) Aralkyl adenosin Derivate und Verfahren zur Herstellung derselben |
| DE2244328A1 (de) * | 1972-09-09 | 1974-03-21 | Boehringer Mannheim Gmbh | Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben |
| US4514405A (en) * | 1981-09-17 | 1985-04-30 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Use of adenosine derivatives as anticonvulsants |
| US5284834A (en) * | 1985-03-29 | 1994-02-08 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Adenosine functionalized congeners as cardiovascular treating agents for animals and methods for using same |
| JPS63208525A (ja) * | 1987-02-25 | 1988-08-30 | Kikkoman Corp | 心不全治療剤 |
| WO1994002497A1 (fr) * | 1992-07-15 | 1994-02-03 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Derives sulfo d'adenosine |
| IL150594A0 (en) * | 2000-01-07 | 2003-02-12 | Ustav Ex Botan Adademie Ved Ce | Purine derivatives, process for their preparation and use |
| CZ294538B6 (cs) * | 2002-12-30 | 2005-01-12 | Ústav Experimentální Botaniky Akademie Vědčeské Re | Substituční deriváty N6-benzyladenosinu, způsob jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující |
| US20070161582A1 (en) * | 2003-08-08 | 2007-07-12 | Dusan Mijikovic | Pharmaceutical compositions and methods for metabolic modulation |
| KR101763656B1 (ko) | 2009-06-29 | 2017-08-01 | 인사이트 홀딩스 코포레이션 | Ｐｉ3ｋ 저해물질로서의 피리미디논 |
| TW201130842A (en) * | 2009-12-18 | 2011-09-16 | Incyte Corp | Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors |
| US8759359B2 (en) * | 2009-12-18 | 2014-06-24 | Incyte Corporation | Substituted heteroaryl fused derivatives as PI3K inhibitors |
| EP2558463A1 (fr) | 2010-04-14 | 2013-02-20 | Incyte Corporation | Dérivés condensés en tant qu'inhibiteurs de i3 |
| WO2011163195A1 (fr) | 2010-06-21 | 2011-12-29 | Incyte Corporation | Dérivés condensés de pyrrole en tant qu'inhibiteurs de pi3k |
| EP3660016A1 (fr) | 2010-12-20 | 2020-06-03 | Incyte Holdings Corporation | N-(1-(phényl substitué)éthyl)-9h-purin-6-amines en tant qu'inhibiteurs de pi3k |
| US9108984B2 (en) | 2011-03-14 | 2015-08-18 | Incyte Corporation | Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors |
| WO2012135009A1 (fr) | 2011-03-25 | 2012-10-04 | Incyte Corporation | Dérivés de pyrimidine-4,6-diamine en tant qu'inhibiteurs de pi3k |
| PT3513793T (pt) | 2011-09-02 | 2021-05-10 | Incyte Holdings Corp | Heterociclilaminas como inibidores de pi3k |
| AR090548A1 (es) | 2012-04-02 | 2014-11-19 | Incyte Corp | Azaheterociclobencilaminas biciclicas como inhibidores de pi3k |
| WO2015191677A1 (fr) | 2014-06-11 | 2015-12-17 | Incyte Corporation | Dérivés d'hétéroarylaminoalkylphényle bicycliques à titre d'inhibiteurs de pi3k |
| SG10201907576SA (en) | 2015-02-27 | 2019-09-27 | Incyte Corp | Salts of pi3k inhibitor and processes for their preparation |
| US9732097B2 (en) | 2015-05-11 | 2017-08-15 | Incyte Corporation | Process for the synthesis of a phosphoinositide 3-kinase inhibitor |
| US9988401B2 (en) | 2015-05-11 | 2018-06-05 | Incyte Corporation | Crystalline forms of a PI3K inhibitor |
| SG11202011680YA (en) | 2018-06-01 | 2020-12-30 | Incyte Corp | Dosing regimen for the treatment of pi3k related disorders |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3014900A (en) * | 1959-01-26 | 1961-12-26 | Upjohn Co | Process for the preparation of ketosidopurines |
-
1967
- 1967-10-18 US US676032A patent/US3506643A/en not_active Expired - Lifetime
- 1967-12-06 CH CH1707167A patent/CH491119A/de not_active IP Right Cessation
- 1967-12-06 CH CH588170A patent/CH509326A/de not_active IP Right Cessation
- 1967-12-07 AT AT1110667A patent/AT276640B/de active
- 1967-12-07 AT AT06861/68A patent/AT277475B/de active
- 1967-12-07 GB GB55647/66A patent/GB1145789A/en not_active Expired
- 1967-12-07 FI FI673279A patent/FI49302C/fi active
- 1967-12-08 FR FR131524A patent/FR1550512A/fr not_active Expired
- 1967-12-08 SE SE16895/67A patent/SE323383B/xx unknown
- 1967-12-08 NL NL6716737A patent/NL130339C/xx active
-
1968
- 1968-03-08 FR FR142941A patent/FR7285M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CH509326A (de) | 1971-06-30 |
| CH491119A (de) | 1970-05-31 |
| GB1145789A (en) | 1969-03-19 |
| FR7285M (fr) | 1969-09-22 |
| AT276640B (de) | 1969-11-25 |
| FR1550512A (fr) | 1968-12-20 |
| SE323383B (fr) | 1970-05-04 |
| AT277475B (de) | 1969-12-29 |
| US3506643A (en) | 1970-04-14 |
| FI49302B (fr) | 1975-01-31 |
| NL130339C (fr) | 1970-12-15 |
| FI49302C (fi) | 1975-05-12 |